InvestorsHub Logo

Amatuer17

01/03/17 9:22 AM

#534 RE: BioSpecialist #533

This product is one with controversy on pricing. Conc increased the price many times and had faced some backlash.

noretreat

01/03/17 10:02 AM

#535 RE: BioSpecialist #533

should end with "WHEN approved by the FDA." HA!